Young cat case links transient myocardial thickening to ATE
Bottom line
A new case report adds a rare wrinkle to feline cardiology: arterial thromboembolism developed in a very young cat with acute myocardial injury and a transient hypertrophic cardiomyopathy-like phenotype, rather than confirmed primary HCM. In the published report, a 7-month-old male British Shorthair developed dyspnea 36 hours after castration, then acute hindlimb paresis, absent femoral pulses, and echocardiographic left ventricular thickening with left atrial enlargement. The cat was treated with oxygen, analgesia, diuresis, antithrombotics, and supportive care, and the myocardial changes later resolved, supporting transient myocardial thickening, or TMT, as the underlying process rather than permanent cardiomyopathy. The report builds on a small but growing literature showing that TMT can occur in young cats, can mimic HCM, and may follow inflammatory, infectious, stressful, or perioperative triggers. (sciencedirect.com)
Why it matters: For veterinary teams, the case is a reminder not to assume that marked wall thickening and thromboembolic complications in a kitten or juvenile cat always mean lifelong HCM. Prior studies suggest TMT often presents with elevated cardiac troponin I, congestive heart failure, and reversible ventricular thickening over weeks to months, although arterial thromboembolism appears to be rare in this setting. That distinction matters for prognosis, follow-up, and conversations with pet parents, because surviving TMT cases may normalize and eventually come off cardiac and antithrombotic drugs, unlike many cats with established cardiomyopathy. (sciencedirect.com)
What to watch: Watch for whether additional case reports clarify how often perioperative stress or myocarditis-like injury in young cats leads to TMT, left atrial dysfunction, and thromboembolic risk. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Case type
- Single case report
- Patient
- 7-month-old male British Shorthair
- Trigger
- Dyspnea began 36 hours after castration
- Clinical signs
- Acute hindlimb paresis and absent femoral pulses
- Cardiac findings
- Left ventricular thickening and left atrial enlargement
- Working diagnosis
- Transient myocardial thickening, not confirmed primary HCM
- Treatment
- Oxygen, analgesia, diuresis, antithrombotics, and supportive care
- Outcome
- Myocardial changes later resolved
A newly reported feline cardiology case highlights an uncommon but clinically important possibility: arterial thromboembolism can accompany acute myocardial injury and transient myocardial thickening in a very young cat, even when the initial presentation looks like hypertrophic cardiomyopathy. In this report, a 7-month-old British Shorthair developed respiratory distress shortly after castration, followed by acute pelvic limb deficits consistent with thromboembolism. The cardiac changes later reversed, pointing to TMT rather than fixed HCM. (sciencedirect.com)
That matters because TMT remains easy to misclassify at first presentation. The syndrome is characterized by reversible left ventricular wall thickening that mimics HCM and is often accompanied by acute myocardial injury, elevated troponin, and congestive heart failure. In the largest retrospective series to date, all 27 cats had evidence of myocardial injury, 25 had congestive heart failure, and the median age was 3 years, reinforcing that this is often a disease of younger cats rather than the older population more typical of classic cardiomyopathy presentations. (sciencedirect.com)
The broader literature suggests that thromboembolism is well recognized in feline cardiomyopathy, but much less so in TMT. A 2025 systematic review described feline arterial thromboembolism as a sudden, life-threatening complication usually linked to left atrial thrombus formation and most often affecting the distal aorta and hind limbs. It also noted that the strongest recognized risk factors include left atrial enlargement, spontaneous echocardiographic contrast, impaired atrial function, and prior thromboembolic events. Those are features that can overlap with TMT during its acute phase, even if TMT ultimately resolves. (mdpi.com)
That overlap is exactly why this case is notable. A previously published 2024 case report described a 1-year-old cat with acute paraparesis, congestive heart failure, spontaneous echo contrast in the left auricle, elevated troponin I and NT-proBNP, and aortic thromboembolism. The cat improved with enoxaparin, clopidogrel, furosemide, pimobendan, analgesia, and supportive care, then normalized echocardiographically within five months and remained healthy years after treatment stopped. The authors argued that, although ATE is common in cats with structural heart disease, this appeared to be the first documented association with TMT and showed that long-term outcome can be favorable. (jlupub.ub.uni-giessen.de)
Other recent reports add context. Case literature has linked TMT to suspected myocarditis, Toxoplasma gondii positivity, Bartonella henselae positivity, postoperative stress, and even acute cholangiohepatitis, though causation is often uncertain. A 2023 retrospective analysis found that a possible cause of myocardial injury was identified in only 14 of 27 cats, and a 2024 postoperative case report suggested even subclinical TMT may decompensate around anesthesia or surgery. Taken together, the evidence supports the idea that TMT is a syndrome with multiple potential triggers, not a single disease entity. (sciencedirect.com)
Expert-style takeaways from the literature are fairly consistent, even where formal commentary is limited. Reviews emphasize that acute feline ATE management still centers on stabilization, analgesia, oxygen as needed, antithrombotic therapy, and treatment of concurrent heart failure, while more aggressive thrombolytic strategies remain controversial because of reperfusion injury, hyperkalemia, acute kidney injury, acidosis, and sudden death. The same 2025 systematic review concluded that standardized evidence-based treatment guidelines are still lacking, although combination long-term antithrombotic strategies such as clopidogrel plus rivaroxaban showed encouraging results in some studies. (mdpi.com)
Why it matters: For veterinary professionals, this case sharpens the differential when a young cat presents with dyspnea, elevated troponin, apparent HCM phenotype, and thromboembolic signs. If the patient is unusually young, has a recent inflammatory or perioperative history, or later shows rapid improvement in atrial size and wall thickness, TMT should stay on the list. That can affect prognosis, duration of therapy, recheck strategy, and how clinicians counsel pet parents. It also argues for serial echocardiography and biomarker follow-up before labeling a juvenile cat with lifelong cardiomyopathy. (pmc.ncbi.nlm.nih.gov)
What to watch: The next question is whether more centers begin reporting TMT-associated thromboembolism in kittens and young cats, and whether pooled data can identify which acute-phase features, such as left atrial enlargement, spontaneous echo contrast, or biomarker elevation, best predict embolic risk and guide the duration of antithrombotic treatment. (mdpi.com)